NAD+ Injectable Vials Recalled Due to Lack of Sterility Assurance
Tailor Made Compounding is recalling 1,856 vials of NAD+ 200mg/mL because the company cannot assure the product meets sterility requirements. The affected vials were distributed nationwide to the United States and Puerto Rico.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for lack of sterility assurance in an injectable product. Although no illnesses or injuries have been reported, the potential risk of infection from non-sterile injectable medication represents a significant harm risk fitting the criterion 'risk-of-harm products where injury has not yet been reported.'
Plain-English summary
Tailor Made Compounding is recalling 1,856 vials of NAD+ 200mg/mL (a 10mL-per-vial injectable product) distributed nationwide to the United States and Puerto Rico. The recall affects multiple batches with expiration dates ranging from March 2022 to September 2022.
The recall is being conducted because the company cannot assure that the product meets sterility requirements. Lack of adequate sterility assurance in injectable medications poses a potential risk of infection for patients who receive the affected product.
Healthcare providers and patients who may have received doses from the affected batches should discontinue use immediately. If you have questions, contact Tailor Made Compounding or your healthcare provider. Patients who have already received injections from recalled vials should consult their healthcare provider to discuss any potential health concerns.
The recalled product
- Product
- NAD+ 200mg/mL, 10mL-vial, Refrigerate, Tailor Made Compounding
- Manufacturer
- TMC Acquisition LLC dba Tailor Made Compounding
- Category
- Drug — Injectable
- Affected units
- 1,856
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Batch#: 10072110A2
- 10142102A2
- Exp 3/22/2022
- 01112205A1
- 11112123A1
- Exp 4/30/2022
- 11222114A1
- 11172107A1
- 11182120A2
- Exp 5/7/2022
- 01102207A1
- 01122211A1
- Exp 5/11/2022
- 12162119A1
- 12162121A1
- Exp 5/24/20220
- 02022223A2
- Exp 6/30/2022
- 03012204A1
- Exp 8/23/2022
Distribution
Part of a larger recall action
This product is one of 52 recalled by TMC Acquisition LLC dba Tailor Made Compounding under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 52 products in this recall →Related recalls
Same manufacturer · TMC Acquisition LLC dba Tailor Made Compounding
See all →- HighDexpanthenol Preservative Free Injectable Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-07-20
- HighHydroxocobalamin Compounded Injections Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
- HighTailor Made Compounding Recalls Glycyrrhizic Acid Injectable for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
- HighFDA Recalls Tailor Made Compounding GAC Injectable Vials for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
- HighEstradiol Cypionate Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15